Just-In-Time Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration
Launched by GEORGIA STATE UNIVERSITY · Nov 23, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help reduce violence in romantic relationships that can happen when people drink alcohol. Researchers believe that sending timely text messages to young adults right before or during drinking can help prevent these incidents. The goal of the study is to see if these messages can help lower both alcohol use and the chances of committing violence against a partner.
To participate in this study, you need to be between 18 and 30 years old, drink alcohol at least twice a week, and have a history of heavy drinking and violence in your romantic relationships recently. If you join, you will receive text messages for 30 days aimed at helping you manage your drinking and relationship behavior. This trial is currently looking for volunteers, and there are no specific exclusions that would prevent someone from participating. It’s a chance to potentially contribute to a solution while also receiving support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-30 years old
- • Consumed alcohol an average of 2 times per week in last 3 months
- • At least two instances of heavy episodic drinking in last month
- • Currently in a romantic relationship
- • History of IPV perpetration within last 3 months
- • Willing to provide cell phone number and carrier and receive text messages for 30 days
- Exclusion Criteria:
- • None
About Georgia State University
Georgia State University is a leading research institution dedicated to advancing knowledge through innovative clinical trials and studies. With a strong emphasis on public health and community well-being, the university leverages its multidisciplinary expertise to conduct rigorous research aimed at addressing pressing health challenges. As a sponsor of clinical trials, Georgia State University fosters collaboration among researchers, healthcare professionals, and community partners, ensuring ethical standards and scientific integrity are upheld throughout the research process. Its commitment to translating research findings into real-world applications positions the university as a key contributor to the advancement of medical science and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Cynthia Stappenbeck, PhD
Principal Investigator
Georgia State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials